Rating History for Phathom Pharmaceuticals (PHAT) by Barclays

More Stocks Rated by Barclays | Latest Ratings for PHAT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/17/2026 Glen Santangelo Maintain Overweight
(N/A)		 14.00
(18.00)		  
 		   Details